KR

Karishma Rajpal

Active Director Designated Partner DIN 11882436
DIN 11882436 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Karishma Rajpal

Karishma Rajpal is a Designated Partner at Indo Gulf Pharmaceuticals International Llp (since 2026).

DIN 11882436
Primary Designation Designated Partner
First Appointment 11 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Aug 20262026Active

Board colleagues of Karishma Rajpal

NameDINCompanyDesignation
Satish Kapoor01931809Indo Gulf Pharmaceuticals International LlpDesignated Partner
Vijay Kapoor01546578Indo Gulf Pharmaceuticals International LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Indo Gulf Pharmaceuticals International Llp
Premium access

Shareholding and investment profile for Karishma Rajpal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karishma Rajpal

Karishma Rajpal currently holds 1 directorship: Indo Gulf Pharmaceuticals International Llp (Designated Partner, since 11 Aug 2026).

Karishma Rajpal was first appointed on 11 Aug 2026 as Designated Partner at Indo Gulf Pharmaceuticals International Llp.

The current boards of Karishma Rajpal's companies include Satish Kapoor (Indo Gulf Pharmaceuticals International Llp), Vijay Kapoor (Indo Gulf Pharmaceuticals International Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available